PAM
ETTX

Panagora Asset Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Panagora Asset Management’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,987
Closed -$39K – 2694
2019
Q2 		$39K Sell
5,987
-2,276
-28% -$14.6K ﹤0.01% 2138
2019
Q1 		$56K Sell
8,263
-1,981
-19% -$11.9K ﹤0.01% 2019
2018
Q4 		$42K Buy
+10,244
New +$67.5K ﹤0.01% 2009

Other funds holding ETTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Panagora Asset Management's ETTX Position: Q3 2019 in Review

Panagora Asset Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2019, closing a stake of 5,987 shares — an estimated $39K sold.

Panagora Asset Management first reported a position in ETTX in Q4 2018 and held it in 3 quarters. The position peaked at $56K in Q1 2019. 21 funds tracked by Wall St. Rank hold ETTX as of Q3 2019.

  • Panagora Asset Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 5,987 Entasis Therapeutics Holdings Inc. shares in Q3 2019, an estimated $39K.
  • Panagora Asset Management first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2018 and held it in 3 quarters.
  • Panagora Asset Management's Entasis Therapeutics Holdings Inc. position peaked at $56K in Q1 2019.
  • 21 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.